Moderna Vaccine Card - Search News

Moderna Stock Falls

Moderna Posts Bigger Loss Than Expected as Vaccine Maker Scales Down Manufacturing

Shares of Moderna, along with other vaccine makers, dropped further this year as lawmakers advanced President Donald Trump's pick for Health and Human Services Secretary, Robert F. Kennedy, through Congress. Kennedy, a vaccine critic, was confirmed to the role on Thursday.

The Wall Street Journal · 4h

Moderna Stock Falls After Vaccine Maker's Wider-Than-Expected Loss

Moderna shares fell after the biotech company swung to a quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion, or $2.91 per share, which included costs to end a contract manufacturing deal and an inventory writedown.

Barron's on MSN · 7h

Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker.

Vaccine maker Moderna had no Valentine’s Day chocolates for investors when its financial results came out Friday. The company had prereported its annual results and previewed its 2025 guidance in mid-January,

Yahoo · 10h

Moderna’s Results Reaffirm a Grim Picture for Vaccine Maker

The vaccine maker Moderna had no Valentine’s Day chocolates for investors when its fourth-quarter financial results came out Friday. Moderna reported fourth-quarter revenue of $1 billion, compared with the consensus estimate of $943 million among analysts tracked by FactSet The company lost $2.

Fierce Biotech10h

Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome

A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...

Moderna says norovirus vaccine trial on FDA clinical hold

Moderna (MRNA) said that the two-season Phase 3 study evaluating the efficacy, safety and immunogenicity of Moderna’s trivalent vaccine against ...

Zacks Investment Research on MSN7d

Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards?

We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before ...

22hon MSN

Moderna Q4 Earnings Preview: COVID-19 Vaccine Sales, Bird Flu Vaccine Candidates On Watch

Moderna is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at what to expect in ...

10h

Moderna Swings to 4Q Loss After Early Launch of Updated Vaccine

Moderna swung to a loss in the last three months of the year after an early launch of its updated Covid-19 vaccine shifted sales out of the fourth quarter.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results